Kallikrein 5 induces atopic dermatitis–like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome
Open accessThe DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Abstract
Netherton syndrome (NS) is a severe genetic skin disease with constant atopic manifestations that is caused by mutations in the serine protease inhibitor Kazal-type 5 (SPINK5) gene, which encodes the protease inhibitor lymphoepithelial Kazal-type–related inhibitor (LEKTI). Lack of LEKTI causes stratum corneum detachment secondary to epidermal proteases hyperactivity. This skin barrier defect favors allergen absorption and is generally regarded as the underlying cause for atopy in NS. We show for the first time that the pro-Th2 cytokine thymic stromal lymphopoietin (TSLP), the thymus and activation-regulated chemokine, and the macrophage-derived chemokine are overexpressed in LEKTI-deficient epidermis. This is part of an original biological cascade in which unregulated kallikrein (KLK) 5 directly activates proteinase-activated receptor 2 and induces nuclear factor κB–mediated overexpression of TSLP, intercellular adhesion molecule 1, tumor necrosis factor α, and IL8. This proinflammatory and proallergic pathway is independent of the primary epithelial failure and is activated under basal conditions in NS keratinocytes. This cell-autonomous process is already established in the epidermis of Spink5−/− embryos, and the resulting proinflammatory microenvironment leads to eosinophilic and mast cell infiltration in a skin graft model in nude mice. Collectively, these data establish that uncontrolled KLK5 activity in NS epidermis can trigger atopic dermatitis (AD)–like lesions, independently of the environment and the adaptive immune system. They illustrate the crucial role of protease signaling in skin inflammation and point to new therapeutic targets for NS as well as candidate genes for AD and atopy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Mutations or variants of genes such as SPINK5 favour the generation of allergen-independent, nonspecific inflammation, providing a pro-T helper 2 (TH2) micromilieu by virtue of keratinocyte-derived alarmins such as thymic stromal lymphopoietin (TSLP), IL-33 and IL-25 (refs52,64).”
From Atopic dermatitis: an expanding therapeutic pipeline for a complex disease (2022) · cites this paper as [52]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The role of the innate immune system in the early phase of AD was demonstrated using animal models52–54 and is likely of clinical relevance in infancy55.”
From Atopic dermatitis: an expanding therapeutic pipeline for a complex disease (2022) · cites this paper as [52]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Williams, H. C., Leung, D. Y. M., Thestrup‐Pedersen, K., & David, T. J. (2000) · Cited by 4,599
Human epithelial cells trigger dendritic cell–mediated allergic inflammation by producing TSLP
Soumelis, V., Reche, P. A., Kanzler, H., Yuan, W., Edward, G., Homey, B., Gilliet, M., Ho, S., Antonenko, S., Lauerma, A., et al. (2002) · Nature Immunology · doi:10.1038/ni805 · Cited by 2,183
The cornified envelope: a model of cell death in the skin
Candi, E., Schmidt, R., & Melino, G. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1619 · Cited by 1,776
Atopic dermatitis and the atopic march
Spergel, J. M., & Paller, A. S. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2003.09.033 · Cited by 1,229
Leung, D. Y., & Bieber, T. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12193-9 · Cited by 1,147
Epidermal growth factor and the multiplication of cultured human epidermal keratinocytes
Rheinwald, J. G., & Green, H. (1977) · Nature · doi:10.1038/265421a0 · Cited by 1,066
Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris
Smith, F. J. D., Irvine, A. D., Terron-Kwiatkowski, A., Sandilands, A., Campbell, L. E., Zhao, Y., Liao, H., Evans, A. T., Goudie, D. R., Lewis-Jones, S., et al. (2006) · Nature Genetics · doi:10.1038/ng1743 · Cited by 1,034 · cited 1×
“Recent genetic studies have shown that loss-of-function mutations in the gene encoding FILAGGRIN underlie ichthyosis vulgaris (6), a very common genetic disorder of keratinization.”
BackgroundMutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome
Chavanas, S., Bodemer, C., Rochat, A., Hamel-Teillac, D., Ali, M., Irvine, A. D., Bonafé, J.-L., Wilkinson, J., Taïeb, A., Barrandon, Y., et al. (2000) · Nature Genetics · doi:10.1038/75977 · Cited by 856 · cited 1×
“We previously identified serine protease inhibitor Kazal-type 5 (SPINK5) as the defective gene in NS (26).”
BackgroundSelf-citationγ-Secretase-mediated proteolysis in cell-surface-receptor signalling
Fortini, M. E. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm910 · Cited by 824
Allakhverdi, Z., Comeau, M. R., Jessup, H. K., Yoon, B.-R. P., Brewer, A., Chartier, S., Paquette, N., Ziegler, S. F., Sarfati, M., & Delespesse, G. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062211 · Cited by 786
Cited by
Items 101–200 of 508
Netherton Syndrome: A Genotype-Phenotype Review
Sarri, C. A., Roussaki‐Schulze, A., Vasilopoulos, Y., Zafiriou, E., Patsatsi, A., Stamatis, C., Gidarokosta, P., Sotiriadis, D., Sarafidou, T., & Mamuris, Z. (2016) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-016-0243-y · Cited by 94
“In addition, the upregulated kallikrein KLK5 induces skin inflammation and allergy [19].”
BackgroundIsolation of SPINK6 in Human Skin
Meyer‐Hoffert, U., Wu, Z., Kantyka, T., Fischer, J., Latendorf, T., Hansmann, B., Bartels, J., He, Y., Gläser, R., & Schröder, J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.091850 · Cited by 105
Çetinarslan, T., Kümper, L., & Fölster‐Holst, R. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1159404 · Cited by 120
“Kallikreins (KLK) are proteases which have various functions including the induction of pro-inflammatory cytokine production by keratinocytes, the degradation of intercellular adhesion molecules, as well as the regulation of barrier integrity (Briot et al., 2009).”
BackgroundEpidermal TSLP: a trigger factor for pathogenesis of atopic dermatitis
Indra, A. K. (2013) · Expert Review of Proteomics · doi:10.1586/14789450.2013.814881 · Cited by 87
Toward Drugs for Protease-Activated Receptor 2 (PAR2)
Yau, M., Liu, L., & Fairlie, D. P. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400638v · Cited by 92
Yokose, U., Ishikawa, J., Morokuma, Y., Naoe, A., Inoue, Y., Yasuda, Y., Tsujimura, H., Fujimura, T., Murase, T., & Hatamochi, A. (2020) · BMC Dermatology · doi:10.1186/s12895-020-00102-1 · Cited by 93
Targeting Skin Barrier Function in Atopic Dermatitis
van den Bogaard, E. H., Elias, P. M., Goleva, E., Berdyshev, E., Smits, J. P. H., Danby, S. G., Cork, M. J., & Leung, D. Y. M. (2023) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2023.02.005 · Cited by 81
Fontao, L., Laffitte, E., Briot, A., Kaya, G., Roux‐Lombard, P., Fraitag, S., Hovnanian, A., & Saurat, J. ‐. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.124 · Cited by 85
Self-citationThe Discovery and Function of Filaggrin
Hoober, J. K., & Eggink, L. L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031455 · Cited by 84
“major effector of the inflammatory response, by KLK5 led to recruitment of eosinophilic and mast cells and formation of lesions [92].”
BackgroundNauroy, P., & Nyström, A. (2019) · Matrix Biology Plus · doi:10.1016/j.mbplus.2019.100019 · Cited by 95
“This leads to an increased production of NFkβdependent cytokines: Thymic Stromal Lymphopoietin (TSLP), IL-8 and TNFα [65].”
BackgroundMarschall, P., Wei, R., Segaud, J., Yao, W., Hener, P., German, B., Meyer, P., Hugel, C., Silva, G. A. D., Braun, R., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.10.006 · Cited by 94
Itch in Atopic Dermatitis – What Is New?
Legat, F. J. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.644760 · Cited by 82
“PAR-2 and TSLP could also be significant “neuro-epidermal communication” elements in AD; in a newly developed mouse model with epidermal overexpression, PAR-2 was recently shown to induce and exacerbate AD signs and symptoms, and especially pruritus (25).”
BackgroundRemodelling of the tumour microenvironment by the kallikrein-related peptidases
Srinivasan, S., Kryza, T., Batra, J., & Clements, J. A. (2022) · Nature reviews. Cancer · doi:10.1038/s41568-021-00436-z · Cited by 95
Czarnowicki, T., He, H., Leonard, A., Malik, K., Magidi, S., Rangel, S. M., Patel, K. R., Ramsey, K., Murphrey, M. B., Song, T., et al. (2018) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.03.1523 · Cited by 95
“These data are supported by studies on a limited number of patients with restricted panels, mostly in NS (Briot et al., 2009; Fontao et al., 2011), showing a pro-Th2/TARC/CCL17/TSLP signature”
BackgroundResultPhysiological and pathological roles of kallikrein-related peptidases in the epidermis
Kishibe, M. (2019) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2019.06.007 · Cited by 80
Infectious Complications in Atopic Dermatitis
Sun, D., & Ong, P. Y. (2016) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2016.08.015 · Cited by 88
“Moreover, activation of kallikrein produces the pro–helper T-cell (TH), TH2, response without allergen priming, thereby interacting with the immune system to promote an inflammatory response.(17)”
Simon, D., Page, B., Vogel, M. T., Bussmann, C., Blanchard, C., Straumann, A., & Simon, H. (2017) · Allergy · doi:10.1111/all.13244 · Cited by 78
“production, the influx of eosinophils and mast cells and atopic dermatitis-like lesions (34).”
BackgroundEpithelial physical barrier defects in chronic rhinosinusitis
Jiao, J., Wang, C., & Zhang, L. (2019) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2019.1601556 · Cited by 79
Danby, S. G., Chittock, J., Brown, K., Albenali, L. H., & Cork, M. J. (2014) · British Journal of Dermatology · doi:10.1111/bjd.12778 · Cited by 77
Sakabe, J., Yamamoto, M., Hirakawa, S., Motoyama, A., Ohta, I., Tatsuno, K., Ito, T., Kabashima, K., Hibino, T., & TOKURA, Y. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.476820 · Cited by 85
Cytokine-Mediated Crosstalk Between Keratinocytes and T Cells in Atopic Dermatitis
Humeau, M., Boniface, K., & Bodet, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.801579 · Cited by 75
Furio, L., & Hovnanian, A. (2014) · Biological Chemistry · doi:10.1515/hsz-2014-0137 · Cited by 88
“In NS patients’ skin, PAR-2 is overexpressed, internalized and constitutively activated by unopposed KLK5 activity (Descargues et al., 2006; Briot et al., 2009, 2010).”
BackgroundSelf-citationAtopic dermatitis: the role of Langerhans cells in disease pathogenesis
Dubrac, S., Schmuth, M., & Ebner, S. (2010) · Immunology & Cell Biology · doi:10.1038/icb.2010.33 · Cited by 74
Bou-Dargham, M. J., Khamis, Z. I., Cognetta, A. B., & Sang, Q. A. (2016) · Medicinal Research Reviews · doi:10.1002/med.21406 · Cited by 79
Protease-Activated Receptor-2 Regulates Neuro-Epidermal Communication in Atopic Dermatitis
Buhl, T., Ikoma, A., Kempkes, C., Cevikbas, F., Sulk, M., Buddenkotte, J., Akiyama, T., Crumrine, D., Camerer, E., Carstens, E. E., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01740 · Cited by 76
“Our findings of an impaired skin barrier in PAR2OE mice with reduced CE thickness and secondary increases in lipid secretion are consistent with earlier descriptions of skin barrier defects induced by excess KLK-induced activation of PAR2, and its restoration by Par2 deficiency (39, 47, 48).”
BackgroundResultInfluentialKallikrein-related peptidases: proteolysis and signaling in cancer, the new frontier
Οικονομοπούλου, Κ., Diamandis, E. P., & Hollenberg, M. D. (2010) · Biological Chemistry · doi:10.1515/bc.2010.038 · Cited by 81
Which Way Do We Go? Complex Interactions in Atopic Dermatitis Pathogenesis
Patrick, G. J., Archer, N. K., & Miller, L. S. (2020) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2020.07.006 · Cited by 85
“The excessive protease activity in Netherton syndrome (described above) also resulted in elevated skin TSLP and Th2 responses (Briot et al. 2009).”
BackgroundHyperactivation of JAK1 tyrosine kinase induces stepwise, progressive pruritic dermatitis
Yasuda, T., Fukada, T., Nishida, K., Nakayama, M., Matsuda, M., Miura, I., Dainichi, T., Fukuda, S., Kabashima, K., Nakaoka, S., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci82887 · Cited by 76
“Among this group of genes, we focused on the expression levels of serine proteases, because it has been reported that a defect in a skin serine protease–specific inhibitor caused hyperactivation of serine proteases, which in turn resulted in an atopic dermatitis–like disease in Netherton syndrome (21).”
BackgroundThe stratum corneum: the rampart of the mammalian body.
Nishifuji, K., & Yoon, J.-S. (2013) · Veterinary dermatology (Print) · doi:10.1111/j.1365-3164.2012.01090.x · Cited by 68
“In addition, Spink5 ⁄ ) embryo skin grafted onto nude mice exhibits parakeratotic hyperkeratosis and desmosomal cleavage resembling human Netherton syndrome.(58,59) It is therefore suggested that regulation of the enzymatic activity of KLKs by LEKTI is crucial for maintaining the normal desquamation process and thus c…”
BackgroundKallikrein-related peptidases: bridges between immune functions and extracellular matrix degradation
Sotiropoulou, G., & Pampalakis, G. (2010) · Biological Chemistry · doi:10.1515/bc.2010.036 · Cited by 74
“The importance of KLK5 was shown in vivo by induction of atopic dermatitis-like lesions through PAR2 in Netherton syndrome (Briot et al., 2009).”
BackgroundNew paradigms in basophil development, regulation and function
Siracusa, M. C., Perrigoue, J. G., Comeau, M. R., & Artis, D. (2010) · Immunology & Cell Biology · doi:10.1038/icb.2010.1 · Cited by 69
Thyssen, J. P., Zirwas, M., & Elias, P. M. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.06.042 · Cited by 68
de Veer, S. J., Furio, L., Swedberg, J. E., Munro, C. A., Brattsand, M., Clements, J. A., Hovnanian, A., & Harris, J. M. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.09.017 · Cited by 69
“…et al., 2006, Yang et al., 2004), defective lipid processing (van Smeden et al., 2014), accelerated filaggrin degradation (Descargues et al., 2005, Hewett et al., 2005), and persistent skin inflammation with severe allergies (Briot et al., 2009, Furio et al., 2014, HannulaJouppi et al., 2014).”
BackgroundSelf-citationFunctional role of kallikrein 5 and proteinase-activated receptor 2 in eosinophilic esophagitis
Azouz, N. P., Klingler, A. M., Pathre, P., Besse, J. A., Morgenstern, N. B.-B., Ballaban, A. Y., Osswald, G. A., Brusilovsky, M., Habel, J. E., Caldwell, J. M., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aaz7773 · Cited by 69
Protease-Activated Receptors and Itch
Akiyama, T., Lerner, E. A., & Carstens, E. (2015) · Handbook of experimental pharmacology · doi:10.1007/978-3-662-44605-8_13 · Cited by 76
“Mutations in the serine protease inhibitor Kazal type 5 (spink5) gene, which encodes the protease inhibitor lymphoepithelial Kazal-type-related inhibitor, result in upregulation of KLK5 activity which is involved in the formation of atopic dermatitis-like skin lesions via PAR-2 (Briot et al. 2009) (Table 1).”
PAR2 Pepducin-Based Suppression of Inflammation and Itch in Atopic Dermatitis Models
Barr, T. P., Garzia, C., Guha, S., Fletcher, E. K., Nguyen, N., Wieschhaus, A. J., Ferrer, L., Covic, L., & Kuliopulos, A. (2018) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.08.019 · Cited by 68
“In particular, PAR2 strongly activates NF-κB– dependent expression of the TSLP cytokine (Briot et al., 2009) and the PZ-235 pepducin suppressed the PAR2-TSLP response to below baseline levels.”
BackgroundTherapeutic Implications of a Barrier-based Pathogenesis of Atopic Dermatitis
Elias, P. M. (2010) · Annals of Dermatology · doi:10.5021/ad.2010.22.3.245 · Cited by 66
Sales, K. U., Friis, S., Konkel, J. E., Godiksen, S., Hatakeyama, M., Hansen, K. K., Rogatto, S. R., Szabo, R., Vogel, L. K., Chen, W., et al. (2014) · Oncogene · doi:10.1038/onc.2013.563 · Cited by 69
“(37), secretion of inflammatory cytokines, including granulocyte-macrophage colonystimulating factor (GM-CSF), interleukin-6 (38), interleukin-8/CXCL1/Gro-1 (35), and thymic stromal lymphopoietin (39), as well as release of prostaglandin (PG)E2 and PGF2a (40), and expression of intercellular cell adhesion molecule-1 (…”
BackgroundJanssens, M., van Smeden, J., Puppels, G. J., Lavrijsen, A. P. M., Caspers, P. J., & Bouwstra, J. A. (2014) · British Journal of Dermatology · doi:10.1111/bjd.12908 · Cited by 75
Involvement of Kallikrein-Related Peptidases in Normal and Pathologic Processes
Stefanini, A. C. B., da Cunha, B. R., Henrique, T., & Tajara, E. H. (2015) · Disease Markers · doi:10.1155/2015/946572 · Cited by 72
“Other skin diseases KLKs 5–8, 10–13, and 15 Increased expression Suggestion of unfavorable prognosis [64–73]”
BackgroundJohnson, J. J., Miller, D. L., Jiang, R., Liu, Y., Shi, Z., Tarwater, L., Williams, R., Balsara, R. D., Sauter, E. R., & Stack, M. S. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.692640 · Cited by 70
“B target genes, including the pro-inflammatory mediators TNF (cid:2) , IL8, ICAM1, and TSLP (16).”
InfluentialProteinases, Their Extracellular Targets, and Inflammatory Signaling
Ramachandran, R., Altier, C., Οικονομοπούλου, Κ., & Hollenberg, M. D. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.010991 · Cited by 72
“Specifically in inflammatory skin settings, a role has been established clinically for KLKs in the pathobiology of Netherton syndrome (Chavanas et al., 2000; Briot et al., 2009, 2010; Hovnanian, 2013).”
BackgroundHouse Dust Mite Increases pro-Th2 Cytokines IL-25 and IL-33 via the Activation of TLR1/6 Signaling
Jang, Y. H., Choi, J. K., Jin, M., Choi, Y., Ryoo, Z. Y., Lee, H., Park, P., Kim, S.-U., Kwon, T. K., Jang, M. H., et al. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2017.03.042 · Cited by 70
“In addition, the activation of NF-kB triggers the production of proinflammatory cytokine in AD (Briot et al., 2009).”
BackgroundCathepsin S Signals via PAR2 and Generates a Novel Tethered Ligand Receptor Agonist
Elmariah, S. B., Reddy, V. B., & Lerner, E. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099702 · Cited by 65
“kallikreins 5 and 7, mast cell tryptase) and the cysteine protease, cathepsin S[4,5].”
BackgroundKhnykin, D., Rønnevig, J., Johnsson, M., Sitek, J. C., Blaas, H.-G. K., Haußer, I., Johansen, F., & Jahnsen, F. L. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2011.04.014 · Cited by 63
de Veer, S. J., Swedberg, J. E., Akcan, M., Rosengren, K. J., Brattsand, M., Craik, D. J., & Harris, J. M. (2015) · Biochemical Journal · doi:10.1042/bj20150412 · Cited by 63
Netherton syndrome subtypes share IL-17/IL-36 signature with distinct IFN-α and allergic responses
Barbieux, C., Claustres, M. B. D., Fahrner, M., Petrova, E., Tsoi, L. C., Gouin, O., Leturcq, F., Nicaise‐Roland, P., Bôle‐Feysot, C., Béziat, V., et al. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2021.08.024 · Cited by 67
Self-citationPeeling off the genetics of atopic dermatitis–like congenital disorders
Samuelov, L., & Sprecher, E. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.07.061 · Cited by 65
Proteinases and their receptors in inflammatory arthritis: an overview
Οικονομοπούλου, Κ., Diamandis, E. P., Hollenberg, M. D., & Chandran, V. (2018) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2018.17 · Cited by 64
Nhu, Q. M., Shirey, K. A., Pennini, M. E., Stiltz, J. A., & Vogel, S. N. (2011) · Innate Immunity · doi:10.1177/1753425910395044 · Cited by 62
“The induction of Th2 differentiation is not limited to the intercellular interactions between antigen-presenting cells, e.g. macrophages and dendritic cells, and T cells; epithelial cell-derived thymic stromal lymphopoietin (TSLP) can also trigger dendritic cell-mediated Th2type inflammation.44 The Th2-promoting role…”
BackgroundLê, T. A., Takai, T., Vu, A. T., Kinoshita, H., Chen, X., Ikeda, S., Ogawa, H., & Okumura, K. (2010) · International Archives of Allergy and Immunology · doi:10.1159/000318679 · Cited by 68
“Very recently, an endogenous protease, kallikrein 5, was found to induce the expression of TSLP in keratinocytes via protease-activated receptor 2 [”
BackgroundKallikrein 7 Promotes Atopic Dermatitis-Associated Itch Independently of Skin Inflammation
Guo, C. J., Mack, M. R., Oetjen, L. K., Trier, A. M., Council, M. L., Pavel, A. B., Guttman-Yassky, E., Kim, B. S., & Liu, Q. (2020) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2019.10.022 · Cited by 59
“, 2007) and implicated in the promotion of AD-like disease in mice (Briot et al., 2009; Furio et al., 2014), we consistently could not detect KLK5 upregulation in AD skin.”
BackgroundDomínguez-Hüttinger, E., Christodoulides, P., Miyauchi, K., Irvine, A. D., Okada-Hatakeyama, M., Kubo, M., & Tanaka, R. J. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.10.026 · Cited by 59
“…peptides (process c), 29 further activates kallikreins (process d), 47 interferes with the de novo production of skin barrier lipids (process e), 42 and triggers inflammation, 43 resulting in AD flares with increased levels of IL-33, 56 thymic stromal lymphopoietin, 44 and other alarmin cytokines.”
Infliximab therapy for Netherton syndrome: A case report
Roda, Â., Sanches, M., Travassos, A. R., Soares‐de‐Almeida, L., & Metze, D. (2017) · JAAD Case Reports · doi:10.1016/j.jdcr.2017.07.019 · Cited by 59
“Recent studies found that thymic stromal lymphopoietin (TSLP) and tumor necrosis factor (TNF)-a are overexpressed in the epidermis of NS patients.(8,9) These findings might be explained by the unrestricted activity of epidermal proteases, including kallikrein 5 (KLK5), caused by LEKTI deficiency.”
BackgroundLee, H., Yoon, N. Y., Lee, N. R., Jung, M., Kim, D. H., & Choi, E. H. (2014) · Experimental Dermatology · doi:10.1111/exd.12525 · Cited by 58
Eosinophilic esophagitis: Immune mechanisms and therapeutic targets
Khokhar, D. S., Marella, S., Idelman, G., Chang, J. W., Chehade, M., & Hogan, S. P. (2022) · Clinical & Experimental Allergy · doi:10.1111/cea.14196 · Cited by 65
Lee, J., Jeon, Y., Lee, Y., & Kim, D. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.03.018 · Cited by 59
Serine protease inhibitors to treat inflammation: a patent review (2011-2016)
Soualmia, F., & Amri, C. E. (2017) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2018.1406478 · Cited by 57
Kouzaki, H., Matsumoto, K., Kikuoka, H., Kato, T., Tojima, I., Shimizu, S., Kita, H., & Shimizu, T. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201603-0529oc · Cited by 60
Dual antibody inhibition of KLK5 and KLK7 for Netherton syndrome and atopic dermatitis
Chavarría‐Smith, J., Chiu, C., Jackman, J. K., Yin, J., Zhang, J., Hackney, J. A., Lin, W., Tyagi, T., Sun, Y., Tao, J., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abp9159 · Cited by 53
Fischer, J., & Meyer‐Hoffert, U. (2013) · Thrombosis and Haemostasis · doi:10.1160/th12-11-0836 · Cited by 51
“The loss-of-function mutations of Spink5 result in elevated protease activity in the epidermis, leading to premature (corneo)desmosome cleavage, abnormal filaggrin maturation, and PAR-2 activation (52-54).”
BackgroundInhibition of kallikrein-related peptidases by the serine protease inhibitor of Kazal-type 6
Kantyka, T., Fischer, J., Wu, Z., Declercq, W., Reiß, K., Schröder, J., & Meyer‐Hoffert, U. (2011) · Peptides · doi:10.1016/j.peptides.2011.03.009 · Cited by 53
Avgeris, M., & Scorilas, A. (2016) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1147560 · Cited by 49
“In vivo studies using experimental mouse models of the NS disease have also underlined the crucial role of the LEKTI–KLK5 interaction in NS, where Spink5 [82,87,88] or transgenic KLK5 mice [89] developed the key clinical features of NS.”
BackgroundInfluentialNatural and engineered kallikrein inhibitors: an emerging pharmacopoeia
Swedberg, J. E., de Veer, S. J., & Harris, J. M. (2010) · Biological Chemistry · doi:10.1515/bc.2010.037 · Cited by 49
Maintz, L., Bieber, T. R. M., Simpson, H. D., & Demessant‐Flavigny, A. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12060893 · Cited by 61
“Experiments in different mouse models [6,7] have suggested that genetics, epigenetics, and non-type 2 unspecific inflammation from the innate immune response likely contribute to the pathophysiologic makeup of the initial phase of AD in the early years.”
BackgroundSelf‐maintenance of neurogenic inflammation contributes to a vicious cycle in skin
Gouin, O., Lebonvallet, N., L’Hérondelle, K., Gall‐Ianotto, C. L., Buhé, V., Plée‐Gautier, E., Carré, J., Lefeuvre, L., & Misery, L. (2015) · Experimental Dermatology · doi:10.1111/exd.12798 · Cited by 49
Nygaard, U., van den Bogaard, E. H. J., Niehues, H., Hvid, M., Deleuran, M. S., Johansen, C., & Vestergaard, C. (2016) · Acta Dermato Venereologica · doi:10.2340/00015555-2552 · Cited by 48
“However, these possible dual functions need further study (50, 51).”
BackgroundAdvances in understanding of Netherton syndrome and therapeutic implications
Petrova, E., & Hovnanian, A. (2020) · Expert Opinion on Orphan Drugs · doi:10.1080/21678707.2020.1857724 · Cited by 51
Self-citationMyers, J. M. B., Martin, L. J., Kovacic, M. B., Baye, T. M., He, H., Pilipenko, V. V., Lindsey, M., Ericksen, M. B., Bernstein, D. I., LeMasters, G. K., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.03.037 · Cited by 44
Hannula‐Jouppi, K., Laasanen, S., Ilander, M. M., Furio, L., Tuomiranta, M., Marttila, R. H., Jeskanen, L., Häyry, V., Kanerva, M., Kivirikko, S., et al. (2016) · JAMA Dermatology · doi:10.1001/jamadermatol.2015.5827 · Cited by 45
Self-citationBP180 dysfunction triggers spontaneous skin inflammation in mice
Zhang, Y., Hwang, B.-J., Liu, Z., Li, N., Lough, K. J., Williams, S. E., Chen, J., Burette, S., Diaz, L. A., Su, M. A., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1721805115 · Cited by 45
“Patients with Netherton syndrome, a severe ichthyosis in which affected individuals have a significant predisposition to AD, have increased levels of TSLP in their skin (33).”
BackgroundBabina, M., Wang, Z., Franke, K., & Zuberbier, T. (2021) · Cells · doi:10.3390/cells10010102 · Cited by 49
Mizuno, K., Morizane, S., Takiguchi, T., & Iwatsuki, K. (2015) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2015.06.016 · Cited by 51
“Recent studies have revealed that TSLP expression is induced by TNF-a, synthetic double-stranded RNA poly (I:C), FSL-1, flagellin, kallikrein 5, and UVB in epidermal keratinocytes [6,21,31,32].”
BackgroundSuccessful treatment with dupilumab of an adult with Netherton syndrome
Andreasen, T. H., Karstensen, H. G., Dunø, M., Lei, U., Zachariae, C. O. C., & Thyssen, J. P. (2020) · Clinical and Experimental Dermatology · doi:10.1111/ced.14317 · Cited by 44
Di, W., Mellerio, J. E., Bernadis, C., Harper, J. I., Abdul‐Wahab, A., Ghani, S., Chan, L., Martinez-Queipo, M., Hara, H., McNicol, A., et al. (2013) · Human Gene Therapy Clinical Development · doi:10.1089/humc.2013.195 · Cited by 67
“Activated KLK5 also stimulates an inflammatory cascade via the protease-activated receptor–NF j B pathway and further impairs skin barrier formation (Briot et al. , 2009; Sales et al. , 2010).”
Jiang, H., Hener, P., Li, J. C., & Li, M. (2012) · Allergy · doi:10.1111/j.1398-9995.2012.02857.x · Cited by 45
“TSLP overproduction has been also reported in the skin of patients with Netherton disease, which is highly associated with AD and atopy (8).”
BackgroundKishibe, M., Bandô, Y., Tanaka, T., Ishida‐Yamamoto, A., Iizuka, H., & Yoshida, S. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.18 · Cited by 42
Niño, G., Huseni, S., Pérez, G. F., Pancham, K., Mubeen, H., Abbasi, A., Wang, J. G., Eng, S., Colberg‐Poley, A. M., Pillai, D. K., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115398 · Cited by 43
Human airway trypsin-like protease, a serine protease involved in respiratory diseases
Menou, A., Duitman, J., Flajolet, P., Sallenave, J., Mailleux, A., & Crestani, B. (2017) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00509.2016 · Cited by 50
“A proinflammatory role of PAR-2 during cutaneous inflammation has already been demonstrated, in humans as well as in mice (59, 129), and the receptor has also been associated with atopic dermatitis (130), rosacea (64), cutaneous neurogenic inflammation (CNI) (41), and the Netherton syndrome (22), which may also be HAT…”
BackgroundKouzaki, H., Matsumoto, K., Kato, T., Tojima, I., Shimizu, S., & Shimizu, T. (2015) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2015.0058 · Cited by 44
Chen, W., Kinsler, V. A., Macmillan, D., & Di, W. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166268 · Cited by 43
Eissa, A., Cretu, D., Soosaipillai, A. R., Thavaneswaran, A., Pellett, F., Diamandis, A., Cevikbas, F., Steinhoff, M. S., Diamandis, E. P., Gladman, D. D., et al. (2012) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2012-0251 · Cited by 41
Kim, M., Mikhaylov, D., Rangel, S. M., Pavel, A. B., He, H., Renert‐Yuval, Y., DUCA, E. D., Malik, K., Huynh, T. N., Ibler, E., et al. (2022) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2022.03.022 · Cited by 49
Profiling Immune Expression to Consider Repurposing Therapeutics for the Ichthyoses
Paller, A. S. (2019) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.08.027 · Cited by 42
“For example, human NS keratinocytes, human keratinocytes incubated with kallikrein 5, and skin from Spink5−/− mice have shown increases in PAR2, TSLP, IL1b, IL8, and TNF mRNA expression (Briot et al., 2009); however, inactivation of PAR2 (protease-activated receptor 2) did not reduce the cutaneous inflammation in an a…”
BackgroundCompound K improves skin barrier function by increasing SPINK5 expression
Park, N.-J., Bong, S.-K., Lee, S., Jung, Y., Jegal, H., Kim, J., Kim, S., Kim, Y. K., & Kim, S.-N. (2019) · Journal of Ginseng Research · doi:10.1016/j.jgr.2019.11.006 · Cited by 41
“In addition, increased expression of PAR2 induces an increase in TSLP, causing an abnormal immune response [22].”
BackgroundSkin Barrier Homeostasis in Atopic Dermatitis: Feedback Regulation of Kallikrein Activity
Tanaka, R. J., Lab), M. O. (., & Harrington, H. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019895 · Cited by 44
“Using this dataset, we calculated the score (PAR2 score) which corresponds to the inflammation level in our model by weighting the expression data of selected possible PAR2 downstream genes (ICAM1, IL8, TNFa, CSF2, IL1a, IL1b, and CCL17 [21,35]).”
BackgroundMethodInfluentialSawada, Y., Honda, T., Nakamizo, S., Nakajima, S., Nonomura, Y., Otsuka, A., Egawa, G., Yoshimoto, T., Nakamura, M., Narumiya, S., et al. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.06.036 · Cited by 42
Cholestasis-Associated Pruritus and Its Pruritogens
Langedijk, J., Beuers, U. H., & Elferink, R. P. J. O. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.639674 · Cited by 49
The Role of Genetics, the Environment, and Epigenetics in Atopic Dermatitis
Mu, Z., & Zhang, J. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-3449-2_4 · Cited by 47
Atopic Dermatitis Itch: Scratching for an Explanation
Soares, G. B., Hashimoto, T., & Yosipovitch, G. (2024) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2023.10.048 · Cited by 44
Interactions Between Keratinocytes and Somatosensory Neurons in Itch
Schwendinger‐Schreck, J., Wilson, S. R., & Bautista, D. M. (2015) · Handbook of experimental pharmacology · doi:10.1007/978-3-662-44605-8_10 · Cited by 39
Belghiti, M., Estévez‐Herrera, J., Giménez‐Garzó, C., González‐Usano, A., Montoliu, C., Ferrer-Montiel, A. V., Felipo, V., & Planells‐Cases, R. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.455162 · Cited by 38
“Moreover, other reports stressed a pivotal role of PAR2 in skin conditions such as in dry-skin itch (35) and in atopic dermatitis (56, 57).”
BackgroundThe role of kallikreins in inflammatory skin disorders and their potential as therapeutic targets
Paolo, C. T. D., Diamandis, E. P., & Prassas, I. (2020) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2020.1775171 · Cited by 42
Nusbaum, A. G., Kirsner, R. S., & Charles, C. A. (2012) · PubMed · Cited by 37
Redhu, D., Franke, K., Aparicio‐Soto, M., Kumari, V., Pažur, K., Illerhaus, A., Hartmann, K., Worm, M., & Babina, M. (2022) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.01.029 · Cited by 38
Radulovic, M., Yoon, H., Larson, N., Wu, J., Linbo, R., Burda, J. E., Diamandis, E. P., Blaber, S. I., Blaber, M., Fehlings, M. G., et al. (2013) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000007 · Cited by 35
“The functional implications of coordinate expression of KLKs and cytokines are not yet known, but regulatory roles are possible based on previous studies demonstrating that KLK6 promotes secretion of IL-6 from astrocytes (28) and KLK5 stimulates production of tumor necrosis factor and IL-8 from keratinocytes (91).”
Lacroix, M., Lacaze-Buzy, L., Furio, L., Tron, E., Valari, M., van der Wier, G., Bodemer, C., Bygum, A., Bursztejn, A. ‐., Gaitanis, G., et al. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.366 · Cited by 35
“This induces severe skin barrier impairment, and production of proallergic and proinflammatory molecules, which have a key role in the development of allergic manifestations in NS (Descargues et al., 2005; Briot et al., 2009; Renner et al., 2009; Bonnart et al., 2010).”
BackgroundMethodInfluentialSelf-citationInomata, N., Nagashima, M., Hakuta, A., & Aihara, M. (2014) · Allergology International · doi:10.1016/j.alit.2014.08.005 · Cited by 40
Agrahari, G., Sah, S. K., Nguyen, C. T., Choi, S. S., Kim, H.-Y., & Kim, T. (2019) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2019.08.434 · Cited by 37
Proteases and proteomics: Cutting to the core of human skin pathologies
de Veer, S. J., Furio, L., Harris, J. M., & Hovnanian, A. (2014) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201300081 · Cited by 35
“Additionally, uncontrolled proteolytic activity leads to activation of protease-activated receptor (PAR)2 which induces expression of pro-inflammatory and pro-allergic signals, such as TSLP, IL8 and tumour necrosis factor- [17].”
BackgroundSelf-citation
Metadata
- Authors
- Briot, A., Deraison, C., Lacroix, M., Bonnart, C., Robin, A., Besson, C., Dubus, P., & Hovnanian, A.
- Affiliations
- Université Toulouse III - Paul Sabatier (FR)
- Institut National de la Santé et de la Recherche Médicale, U563, Toulouse F-31300, France 1
- Université Bordeaux Segalen (FR)
- Corresponding author
- Hovnanian, Alain
- ORCID
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2009-05-04
- Volume
- 206
- Issue
- 5
- Pages
- 1135-1147
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2715042
- OpenAlex
- W2144344238
- Cited by
- 504
- References
- 71
- Citations by year
- 2026: 17 · 2025: 14 · 2024: 22 · 2023: 18 · 2022: 32 · 2021: 24 · 2020: 30 · 2019: 37 · 2018: 22 · 2017: 31 · 2016: 40 · 2015: 30 · 2014: 42 · 2013: 42 · 2012: 33
- FWCI
- 42.73
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Funders
- Agence Nationale de la Recherche (ANR-05-MRAR-0009)
- Topics
- Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Skin and Cellular Biology Research
- Health Sciences › Medicine › Dermatology › Genetic and rare skin diseases.
- Keywords
- Netherton syndrome, kallikrein 5, SPINK5, LEKTI, atopic dermatitis, protease-activated receptor 2, thymic stromal lymphopoietin, keratinocytes, NF-κB signaling, Th2 cytokines, skin barrier dysfunction, eosinophilic dermatitis, mast cell infiltration, protease signaling, atopy
- MeSH terms
- Serine Peptidase Inhibitor Kazal-Type 5, Animals, Dermatitis, Atopic, Epidermis, Inflammation, Kallikreins, Mice, Nude, Skin, Serpins, Skin Transplantation, Mice, Knockout, Dermis, Mice, Keratin-14
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.